跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA DR. REDDYS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA DR. REDDYS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Reddy Pharma Iberia S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 19, 2023
Approval ID
955eec30b97d2a3b
Company
Reddy Pharma Iberia S.A.
Type
Standard
Approval Details
Approval Id
955eec30b97d2a3b
Drug Cima Aemps Name
SITAGLIPTINA DR. REDDYS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88513
Holder Company Name
Reddy Pharma Iberia S.A.
Marketing Company Name
Reddy Pharma Iberia S.A.
Authorization Date
2023-01-19
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Reddy Pharma Iberia S.A.
Active Ingredients
SITAGLIPTINA HIDROCLORURO MONOHIDRATO
28,34 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 19, 2023
Approval ID
955eec30b97d2a3b
Type
Standard
Back to CIMA-AEMPS Approvals
SITAGLIPTINA DR. REDDYS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
